ATLANTA, July 24, 2007 (PRIME NEWSWIRE) -- Tikvah Therapeutics, Inc. (Tikvah) and Academia Sinica of Taipei, Taiwan announced today that Tikvah has entered into an exclusive licensing agreement for a number of patent and patent applications with Academia Sinica encompassing the diagnosis, methods of use, and treatments of a variety of neurodegenerative disorders, including, amongst others, spinal muscular atrophy.
